GlobeNewswire 2020-10-23 Cyclacel Pharmaceuticals Announces Appointment of Mark Kirschbaum, M.D., as Chief Medical Officer
GlobeNewswire 2020-10-05 Cyclacel Pharmaceuticals to Present at the October 2020 Lytham Partners Virtual Investor Growth Conf...
GlobeNewswire 2020-09-21 Cyclacel Announces Fadraciclib Abstract Selected for Oral Presentation in the Late Breaking and Best...
GlobeNewswire 2020-09-10 Opthea Appoints US-Based Non-Executive Director
GlobeNewswire 2020-08-12 Cyclacel Pharmaceuticals Reports Second Quarter 2020 Financial Results
GlobeNewswire 2020-08-05 Cyclacel Pharmaceuticals to Release Second Quarter 2020 Financial Results
GlobeNewswire 2020-08-04 Biopharmaceutical Leader Robert J. Spiegel, MD, FACP Appointed to the Athenex Board of Directors
GlobeNewswire 2020-07-13 Cyclacel’s Clinical Stage CDK2/9 Inhibitor Fadraciclib Targets Key Anti-Apoptotic and Oncogenic Path...
GlobeNewswire 2020-05-12 Cyclacel Pharmaceuticals Reports First Quarter 2020 Financial Results
GlobeNewswire 2020-05-05 Cyclacel Pharmaceuticals to Release First Quarter 2020 Financial Results
GlobeNewswire 2020-04-24 Cyclacel Announces Closing of $20 Million Public Offering
GlobeNewswire 2020-04-21 CYCLACEL ANNOUNCES PRICING OF $20 MILLION PUBLIC OFFERING
GlobeNewswire 2020-04-20 Cyclacel Pharmaceuticals Announces Collaboration With the University of Edinburgh to Study Its CDK I...
GlobeNewswire 2020-04-14 Cyclacel Announces Reverse Stock Split
GlobeNewswire 2020-02-26 Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2019 Financial Results
GlobeNewswire 2020-02-19 Cyclacel Pharmaceuticals to Release Fourth Quarter and Full Year 2019 Financial Results
GlobeNewswire 2020-02-03 Cyclacel Pharmaceuticals to Present at the 2020 BIO CEO & Investor Conference
GlobeNewswire 2020-01-13 Cyclacel Pharmaceuticals Reviews 2019 Achievements and Announces Key Business Objectives for 2020
GlobeNewswire 2020-01-06 Cyclacel Pharmaceuticals to Present at Biotech Showcase™ 2020 in San Francisco
GlobeNewswire 2019-12-09 Cyclacel’s CYC065 and Venetoclax Demonstrate Therapeutic Potential and Anticancer Activity in Acute ...
GlobeNewswire 2019-11-13 Cyclacel Pharmaceuticals Reports Third Quarter 2019 Financial Results
GlobeNewswire 2019-11-07 Cyclacel Pharmaceuticals to Release Third Quarter 2019 Financial Results
GlobeNewswire 2019-11-06 Cyclacel Pharmaceuticals Announces Multiple Clinical Abstracts Selected for Presentation at the ASH ...
GlobeNewswire 2019-09-23 Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2019 Healthcare Conference
GlobeNewswire 2019-09-09 Cyclacel Pharmaceuticals Announces First Patient Treated With Oral CYC065 in a Phase 1 Study in Pati...